⌘K

Login Start Free

Home/Filings/4/0000905718-22-000032

4//SEC Filing

Jambulingam Thani 4

Accession 0000905718-22-000032

CIK 0001708331other

View on SEC.gov Company Profile

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 5:33 PM ET

Size

5.2 KB

Accession

0000905718-22-000032

Insider Transaction Report

Form 4

Period: 2022-01-01

Virpax Pharmaceuticals, Inc.VRPX

Jambulingam Thani

Director

Transactions

Award
Stock Option (right to buy)
2022-01-01+14,113→ 14,113 total
Exercise: $3.43From: 2023-01-01Exp: 2032-01-01→ Common Stock (14,113 underlying)

Documents

1 file

4
virpax_fm4jan12022.xmlPrimary

Issuer

Virpax Pharmaceuticals, Inc.

CIK 0001708331

Entity typeother

Related Parties

1

filerCIK 0001818466

Filing Metadata

Form type: 4
Filed: Jan 4, 7:00 PM ET
Accepted: Jan 5, 5:33 PM ET
Size: 5.2 KB

View on SEC.gov